Leaderboard

En | De
Sie sind hier: Gastroenterologie » Leber » Anderes 30. Oktober 2024
Suchen
medline.ch
Anderes
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Hepatitis
Leberzirrhose
Neoplasie
Portale Hypertonie
Anderes
Magen-Darm
Oesophagus
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3426  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 68508  
   
Dual peroxisome proliferator-activated receptor α/δ agonists: Hope for the treatment of alcohol-associated liver disease?
World J Gastroenterol
Zhang XY, Chen QJ, Zhu F, Li M, Shang D.
PMID: 39474402 [PubMed - indexed for MEDLINE]


Pictorial review of hepatic echinococcosis: Ultrasound imaging and differential diagnosis.
World J Gastroenterol
Tao Y, Wang YF, Wang J, Long S, Seyler BC, Zhong XF, Lu Q.
PMID: 39474399 [PubMed - indexed for MEDLINE]


Outcomes of patients with acute liver failure not listed for liver transplantation: A cohort analysis.
Hepatol Commun
Dong V, Durkalski V, Lee WM, Karvellas CJ, and the United States Acute Liver Failure Study Group.
PMID: 39470433 [PubMed - indexed for MEDLINE]


Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
Radiology
Ferraioli G, Roccarina D, Barr RG.
PMID: 39470421 [PubMed - indexed for MEDLINE]


Vibrio vulnificus infection complicated by acute-on-chronic liver failure: A case report.
Medicine (Baltimore)
Wang T, Huang Q.
PMID: 39465726 [PubMed - indexed for MEDLINE]


Causal relationships between three plasma proteins and non-alcoholic fatty liver disease, mediated by Epstein-Barr virus EA-D antibody levels: a mendelian randomization study.
Sci Rep
Ming R, Wu H, Wu Z.
PMID: 39463412 [PubMed - indexed for MEDLINE]


Identification of diagnostic markers pyrodeath-related genes in non-alcoholic fatty liver disease based on machine learning and experiment validation.
Sci Rep
Lei L, Li J, Liu Z, Zhang D, Liu Z, Wang Q, Gao Y, Mo B, Li J.
PMID: 39462099 [PubMed - indexed for MEDLINE]


Association between Liver Damage and Disease Progression Markers with Mortality Risk and Mechanical Ventilation in Hospitalized COVID-19 Patients: A Nationwide Retrospective SARSTer Study.
Viruses
, Jaroszewicz J, Zar, Rogalska M, Czupryna P, Rorat M, Kozielewicz D, Maciukaj, Kiciak S, Kr, Dutkiewicz E, Stojko M, Spycha, Ciechanowski P, Bolewska B, Podlasin R, Flisiak R.
PMID: 39459864 [PubMed - indexed for MEDLINE]


Saccharomyces boulardii Mitigates Fructose-Induced Non-Alcoholic Fatty Liver in Rats.
Medicina (Kaunas)
Ulusan M, Erdogan MA, Simsek O, Gunes V, Erbas O.
PMID: 39459500 [PubMed - indexed for MEDLINE]


Analysis of Complications of a Neglected Disease: 13 Years of Experience with Liver Hydatid Cysts in a High-Volume Hospital.
Medicina (Kaunas)
Azizo, Aydogdu B, Kamci TO, Arslan S, Basuguy E, Bilici S, Okur MH.
PMID: 39459483 [PubMed - indexed for MEDLINE]


Acacetin, a Natural Flavone with Potential in Improving Liver Disease Based on Its Anti-Inflammation, Anti-Cancer, Anti-Infection and Other Effects.
Molecules
Chen K, Gao Z.
PMID: 39459239 [PubMed - indexed for MEDLINE]


Association of the Composite Dietary Antioxidant Index and Consumption Time with NAFLD: The U.S. National Health and Nutrition Examination Survey, 2017-2020.
Nutrients
Zhang K, Xu Y, Zhang N, Liang X, Zhang H, Liang H.
PMID: 39458550 [PubMed - indexed for MEDLINE]


The Role of Dietary Ingredients and Herbs in the Prevention of Non-Communicable Chronic Liver Disease.
Nutrients
Ma, Dziubyna T, Jamer T, Slivinskyi D, Pytrus T, Neubauer K, Zwoli, Stawarski A, Piotrowska E, Nowacki D.
PMID: 39458499 [PubMed - indexed for MEDLINE]


Flavonoids and Their Role in Preventing the Development and Progression of MAFLD by Modifying the Microbiota.
Int J Mol Sci
Sokal-Dembowska A, Jarmakiewicz-Czaja S, Filip R.
PMID: 39456969 [PubMed - indexed for MEDLINE]


Computational Strategies for Assessing Adverse Outcome Pathways: Hepatic Steatosis as a Case Study.
Int J Mol Sci
Ortega-Vallbona R, Palomino-Schätzlein M, Tolosa L, Benfenati E, Ecker GF, Gozalbes R, Serrano-Candelas E.
PMID: 39456937 [PubMed - indexed for MEDLINE]


Potential Drawbacks of Noninvasive Diagnostic Methods for Nonalcoholic Fatty Liver Disease.
J Am Board Fam Med
Khayyat YM.
PMID: 39455269 [PubMed - indexed for MEDLINE]


[Prevalence and clinical associations of steatotic liver disease in a Preventive Medicine Unit: A cross-sectional study].
Rev Med Chil
Pérez-Valenzuela J, Aguirre H, Martínez L, Castro L, Mezzano G.
PMID: 39450796 [PubMed - indexed for MEDLINE]


Gut‑liver axis in liver disease: From basic science to clinical treatment (Review).
Mol Med Rep
Wang J, Wang X, Zhuo E, Chen B, Chan S.
PMID: 39450549 [PubMed - indexed for MEDLINE]


Clinical significance of serum FGF21 levels in diagnosing nonalcoholic fatty liver disease early.
Sci Rep
Xu K, He BW, Yu JL, Kang HM, Zheng TT, Chen ZY, Li JS.
PMID: 39448761 [PubMed - indexed for MEDLINE]


Mitochondrial quality control in alcohol-associated liver disease.
Hepatol Commun
Thoudam T, Gao H, Jiang Y, Huda N, Yang Z, Ma J, Liangpunsakul S.
PMID: 39445886 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 68508    Seite 1 von 3426  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Benutzername

Passwort

 

 

Haben Sie Ihr Passwort vergessen?

 

Neu bei My Medline?

Melden Sie sich bei My Medline an!

 

Mehr über My Medline erfahren

mehr >>

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1